CancerPACT Act 2022
Hematologic Cancer (Leukemias, Multiple Myeloma, and Related)
Typical VA Rating Range
100%
Actual ratings are assigned by VA raters based on C&P exam findings. This range reflects typical outcomes for veterans with this condition.
About This Condition
Cancers of the blood and bone marrow, including the acute and chronic leukemias, multiple myeloma, myelodysplastic syndromes, and myelofibrosis. VA recognizes these hematologic cancers as PACT Act presumptive conditions (added through VA rulemaking effective in early 2025). Active disease is rated at 100%, with re-evaluation after treatment.
Evidence Needed
- Pathology / bone marrow biopsy confirming the hematologic cancer
- Blood counts and flow cytometry
- Hematology/oncology treatment records
- Documentation of qualifying deployment
ICD-10 Codes
C90.00C91.90C92.90C94.6D46.9D47.1
These ICD-10 codes should appear in your medical records and VA examination reports. Your physician and VA rater will use these codes to document the condition.
Next Step
Think this condition applies to you? Check your full PACT Act eligibility — we'll assess your service history, deployment locations, and all applicable conditions.